Background：CD229, also known as Ly9 and SLAMF3, is a 120 kDa type I transmembrane glycoprotein in the SLAM subgroup of the CD2 family.
Signaling lymphocyte activation molecule (SLAM) family receptors are critically involved in modulating innate and adaptive immune responses.
CD229 is expressed on T and B cells, thymocytes, and more weakly on NK cells.
Homophilic binding between CD229 molecules is mediated by the N-terminal Ig-like domain.
仕様
サイズ：25ug
Source：Biotinylated Human CD229, His,Avitag (CD9-H82E6) is expressed from human 293 cells (HEK293). It contains AA Lys 48 - Lys 454 (Accession # Q9HBG7-1).
Molecule：CD229
Synonyms：SLAMF3,LY9,Ly-9,hly9,Ly9
Species：Human
Tag：His Tag & Avi Tag
Expression Systems：HEK293
Expression Rigeion：Lys 48 - Lys 454
Conjugate：Precision Avi
Accession：NP_002339.2
Molecular Weight：48.5 kDa
Characteristics：This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag). The protein has a calculated MW of 48.5 kDa. The protein migrates as 60-70 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin Level：Less than 1.0 EU per ug by the LAL method.
